Acta Neurochirurgica

, Volume 155, Issue 9, pp 1637–1645 | Cite as

Health-related quality of life and psychiatric symptoms improve effectively within a short time in patients surgically treated for pituitary tumors—a longitudinal study of 106 patients

  • Monika Milian
  • Juergen Honegger
  • Christine Gerlach
  • Tsambika Psaras
Clinical Article - Brain Tumors
First Online:
Received:
Accepted:

Abstract

Background

Reduced health-related quality of life (HRQoL) is a common complaint in patients suffering from pituitary tumors. Although successful tumor treatment has been reported to lead to an improvement in perceived HRQoL, the temporal gradient at which these improvements occur has not been fully addressed.

Methods

Using three validated health-related questionnaires (SF-36, SCL-90-R, QLS-H), we assessed HRQoL in 106 adult patients harboring pituitary tumors (mean age 48.0 ± 16.0 years) before as well as 3 and 12 months after initiation of treatment. The AcroQoL questionnaire was additionally applied in acromegalic patients.

Results

There was a significant improvement in all but one scale (role-physical) of the SF-36 questionnaire and all but two scales (interpersonal sensitivity, paranoid ideation) of the SCL-90-R, the QLS-H score and the AcroQoL subscales within 3 months after surgical treatment. The trend to amelioration continued at the 12 month re-assessment, but did not reach statistical significance. Linear regression analyses revealed that younger age and male gender favor a more distinct improvement of HRQoL after treatment.

Conclusions

HRQoL is considerably reduced before treatment for pituitary disease. Improvement is an early postoperative phenomenon and occurs within 3 months after treatment. Men and younger patients are more likely to improve within this time span.

Keywords

Health-related quality of life Psychiatric symptoms Pituitary tumor Longitudinal course 

Abbreviations

AC

Acromegaly

AcroQoL

Acromegaly Quality of Life Questionnaire

CD

Cushing’s disease

fT3

Free tri-iodothyronine

fT4

Free thyroxine

SF-36

Short Form-36

SCL-90-R

Symptom Checklist 90-Revised

HRQoL

Health related quality of life

QLS-H

Questions on Life Satisfaction-Hypopituitarism

This is a preview of subscription content, log in to check access.

Notes

Conflicts of interest

None.

References

  1. 1.
    Biermasz NR, van Thiel SW, Pereira AM, Hoftijzer HC, van Hemert AM, Smit JW, Romijn JA, Roelfsema F (2004) Decreased quality of life in patients with acromegaly despite long-term cure of growth hormone excess. J Clin Endocrinol Metab 89:5369–5376PubMedCrossRefGoogle Scholar
  2. 2.
    Blum A, Maser E (2003) Enzymology and molecular biology of glucocorticoid metabolism in humans. Prog Nucleic Acid Res Mol Biol 75:173–216PubMedCrossRefGoogle Scholar
  3. 3.
    Bullinger M, Kirchberger I (1998) SF-36. Fragebogen zum Gesundheitszustand. Handanweisung. Hogrefe, GöttingenGoogle Scholar
  4. 4.
    Burman P, Deijen JB (1998) Quality of life and cognitive function in patients with pituitary insufficiency. Psychother Psychosom 67:154–167, ReviewPubMedCrossRefGoogle Scholar
  5. 5.
    Comtois R, Beauregard H, Somma M, Serri O, Aris-Jilwan N, Hardy J (1991) The clinical and endocrine outcome to trans-sphenoidal microsurgery of nonsecreting pituitary adenomas. Cancer 68:860–866PubMedCrossRefGoogle Scholar
  6. 6.
    Dekkers OM, van der Klaauw AA, Pereira AM, Biermasz NR, Honkoop PJ, Roelfsema F, Smit JW, Romijn JA (2006) Quality of life is decreased after treatment for nonfunctioning pituitary macroadenoma. J Clin Endocrinol Metab 91:3364–3369PubMedCrossRefGoogle Scholar
  7. 7.
    Dorn LD, Burgess ES, Friedman TC, Dubbert B, Gold PW, Chrousos GP (1997) The longitudinal course of psychopathology in Cushing's syndrome after correction of hypercortisolism. J Clin Endocrinol Metab 82:912–919PubMedCrossRefGoogle Scholar
  8. 8.
    Ebersold MJ, Quast LM, Laws ER Jr, Scheithauer B, Randall RV (1986) Long-term results in transsphenoidal removal of nonfunctioning pituitary adenomas. J Neurosurg 64:713–719PubMedCrossRefGoogle Scholar
  9. 9.
    Feldkamp J, Santen R, Harms E, Aulich A, Mödder U, Scherbaum WA (1999) Incidentally discovered pituitary lesions: high frequency of macroadenomas and hormone-secreting adenomas - results of a prospective study. Clin Endocrinol [Oxf] 51:109–113CrossRefGoogle Scholar
  10. 10.
    Flitsch J, Spitzner S, Lüdecke DK (2000) Emotional disorders in patients with different types of pituitary adenomas and factors affecting the diagnostic process. Exp Clin Endocrinol Diabetes 108:480–485PubMedCrossRefGoogle Scholar
  11. 11.
    Franke G (1995) Die Symptom-Checkliste von Derogatis - Deutsche Version—[SCL-90-R]. Manual. Beltz Test GmbH, GöttingenGoogle Scholar
  12. 12.
    Furman K, Ezzat S (1998) Psychological features of acromegaly. Psychother Psychosom 67:147–153, ReviewPubMedCrossRefGoogle Scholar
  13. 13.
    Herschbach P, Henrich G, Strasburger CJ, Feldmeier H, Marín F, Attanasio AM, Blum WF (2001) Development and psychometric properties of a disease-specific quality of life questionnaire for adult patients with growth hormone deficiency. Eur J Endocrinol 145:255–265PubMedCrossRefGoogle Scholar
  14. 14.
    Johnson MD, Woodburn CJ, Vance ML (2003) Quality of life in patients with a pituitary adenoma. Pituitary 6:81–87PubMedCrossRefGoogle Scholar
  15. 15.
    Kauppinen-Mäkelin R, Sane T, Sintonen H, Markkanen H, Välimäki MJ, Löyttyniemi E, Niskanen L, Reunanen A, Stenman UH (2006) Quality of life in treated patients with acromegaly. J Clin Endocrinol Metab 91:3891–3896PubMedCrossRefGoogle Scholar
  16. 16.
    Kelly WF, Kelly MJ, Faragher B (1996) A prospective study of psychiatric and psychological aspects of Cushing's syndrome. Clin Endocrinol [Oxf] 45:715–720CrossRefGoogle Scholar
  17. 17.
    Korali Z, Wittchen HU, Pfister H, Höfler M, Oefelein W, Stalla GK (2003) Are patients with pituitary adenomas at an increased risk of mental disorders? Acta Psychiatr Scand 107:60–68PubMedCrossRefGoogle Scholar
  18. 18.
    Lindsay JR, Nansel T, Baid S, Gumowski J, Nieman LK (2006) Long-term impaired quality of life in Cushing's syndrome despite initial improvement after surgical remission. J Clin Endocrinol Metab 91:447–453PubMedCrossRefGoogle Scholar
  19. 19.
    Marazuela M, Astigarraga B, Vicente A, Estrada J, Cuerda C, García-Uría J, Lucas T (1994) Recovery of visual and endocrine function following transsphenoidal surgery of large nonfunctioning pituitary adenomas. J Endocrinol Investig 17:703–707Google Scholar
  20. 20.
    McComb DJ, Ryan N, Horvath E, Kovacs K (1983) Subclinical adenomas of the human pituitary. New light on old problems. Arch Pathol Lab Med 107:488–491PubMedGoogle Scholar
  21. 21.
    Nomikos P, Ladar C, Fahlbusch R, Buchfelder M (2004) Impact of primary surgery on pituitary function in patients with non-functioning pituitary adenomas – a study on 721 patients. Acta Neurochir (Wien) 146:27–35, Erratum in: Acta Neurochir [Wien] 2004, 146:433CrossRefGoogle Scholar
  22. 22.
    Paisley AN, Trainer PJ (2003) Medical treatment in acromegaly. Curr Opin Pharmacol 3:672–677PubMedCrossRefGoogle Scholar
  23. 23.
    Pantanetti P, Sonino N, Arnaldi G, Boscaro M (2002) Self image and quality of life in acromegaly. Pituitary 5:17–19, ReviewPubMedCrossRefGoogle Scholar
  24. 24.
    Rosilio M, Blum WF, Edwards DJ, Shavrikova EP, Valle D, Lamberts SW, Erfurth EM, Webb SM, Ross RJ, Chihara K, Henrich G, Herschbach P, Attanasio AF (2004) Long-term improvement of quality of life during growth hormone [GH] replacement therapy in adults with GH deficiency, as measured by questions on life satisfaction-hypopituitarism [QLS-H]. J Clin Endocrinol Metab 89:1684–1693PubMedCrossRefGoogle Scholar
  25. 25.
    Rowles SV, Prieto L, Badia X, Shalet SM, Webb SM, Trainer PJ (2005) Quality of life [QOL] in patients with acromegaly is severely impaired: use of a novel measure of QOL: acromegaly quality of life questionnaire. J Clin Endocrinol Metab 90:3337–3341PubMedCrossRefGoogle Scholar
  26. 26.
    Sardella C, Lombardi M, Rossi G, Cosci C, Brogioni S, Scattina I, Webb SM, Gasperi M, Martino E, Bogazzi F (2010) Short- and long-term changes of quality of life in patients with acromegaly: results from a prospective study. J Endocrinol Investig 33:20–25Google Scholar
  27. 27.
    van Aken MO, Lamberts SW (2005) Diagnosis and treatment of hypopituitarism: an update. Pituitary 8:183–191, ReviewPubMedCrossRefGoogle Scholar
  28. 28.
    Ware JE Jr, Sherbourne CD (1992) The MOS 36-item short form health survey [SF-36]. Conceptual framework and item selection. Med Care 30:473–474PubMedCrossRefGoogle Scholar
  29. 29.
    Webb SM, Badia X (2007) Quality of life in growth hormone deficiency and acromegaly. Endocrinol Metab Clin North Am 36:221–232, ReviewPubMedCrossRefGoogle Scholar
  30. 30.
    Webb SM, Badia X, Surinach NL, Spanish AcroQoL Study Group (2006) Validity and clinical applicability of the acromegaly quality of life questionnaire, AcroQoL: a 6-month prospective study. Eur J Endocrinol 155:269–277PubMedCrossRefGoogle Scholar
  31. 31.
    Webb SM (2006) Quality of life in acromegaly. Neuroendocrinology 83:224–229PubMedCrossRefGoogle Scholar
  32. 32.
    Webb SM, Prieto L, Badia X, Albareda M, Catalá M, Gaztambide S, Lucas T, Páramo C, Picó A, Lucas A, Halperin I, Obiols G, Astorga R (2002) Acromegaly Quality of Life Questionnaire [ACROQOL] a new health-related quality of life questionnaire for patients with acromegaly: development and psychometric properties. Clin Endocrinol [Oxf] 57:251–258CrossRefGoogle Scholar
  33. 33.
    Wichers-Rother M, Hoven S, Kristof RA, Bliesener N, Stoffel-Wagner B (2004) Non-functioning pituitary adenomas: endocrinological and clinical outcome after transsphenoidal and transcranial surgery. Exp Clin Endocrinol Diabetes 112:323–327PubMedCrossRefGoogle Scholar
  34. 34.
    Yanovski JA, Cutler GB Jr (1994) Glucocorticoid action and the clinical features of Cushing's syndrome. Endocrinol Metab Clin N Am 23:487–509, ReviewGoogle Scholar

Copyright information

© Springer-Verlag Wien 2013

Authors and Affiliations

  • Monika Milian
    • 1
  • Juergen Honegger
    • 1
  • Christine Gerlach
    • 1
  • Tsambika Psaras
    • 1
  1. 1.Department of NeurosurgeryUniversity Hospital TuebingenTuebingenGermany

Personalised recommendations